| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10764321 | Biochemical and Biophysical Research Communications | 2010 | 4 Pages |
Abstract
⺠Sclerostin interacts with the carboxyl-terminal domain of the erbB-3 receptor. ⺠Sclerostin increases erbB-3 receptor signaling following treatment of cells with neuregulin/heregulin. ⺠Modulation of EGF/erbB signaling in bone by sclerostin is one of the mechanisms by which sclerostin controls bone growth.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Theodore A. Craig, Rajiv Kumar,